These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Patient-reported reasons for the discontinuation of commonly used treatments for moderate to severe psoriasis. Yeung H, Wan J, Van Voorhees AS, Callis Duffin K, Krueger GG, Kalb RE, Weisman JD, Sperber BR, Brod BA, Schleicher SM, Bebo BF, Shin DB, Troxel AB, Gelfand JM. J Am Acad Dermatol; 2013 Jan; 68(1):64-72. PubMed ID: 22846688 [Abstract] [Full Text] [Related]
5. Combining traditional agents and biologics for the treatment of psoriasis. Cather JC, Menter A. Semin Cutan Med Surg; 2005 Mar; 24(1):37-45. PubMed ID: 15900797 [Abstract] [Full Text] [Related]
9. [Biologics in the treatment of psoriasis]. Dissemond J, Grabbe S. MMW Fortschr Med; 2006 Sep 21; 148(38):42-4. PubMed ID: 17036963 [Abstract] [Full Text] [Related]
10. [Treatment of plaque psoriasis with biologics. A meta-analysis of randomized controlled trials]. Zhang Z, Schmitt J, Wozel G, Kirch W. Med Klin (Munich); 2009 Feb 15; 104(2):125-36. PubMed ID: 19242664 [Abstract] [Full Text] [Related]
11. Efficacy of systemic treatments for moderate to severe plaque psoriasis: systematic review and meta-analysis. Bansback N, Sizto S, Sun H, Feldman S, Willian MK, Anis A. Dermatology; 2009 Feb 15; 219(3):209-18. PubMed ID: 19657180 [Abstract] [Full Text] [Related]
19. Tolerability and safety of biological therapies for psoriasis in daily clinical practice: a study of 103 Italian patients. Brunasso AM, Puntoni M, Salvini C, Delfino C, Curcic P, Gulia A, Massone C. Acta Derm Venereol; 2011 Jan 15; 91(1):44-9. PubMed ID: 21088813 [Abstract] [Full Text] [Related]
20. Biologic therapies in psoriasis: a new therapeutic approach. Gisondi P, Girolomoni G. Autoimmun Rev; 2007 Sep 15; 6(8):515-9. PubMed ID: 17854741 [Abstract] [Full Text] [Related] Page: [Next] [New Search]